✦ LIBER ✦

Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives

✍ Scribed by Jeanne Loughlin; John D. Seeger; P. Mona Eng; Marie Foegh; C. Robin Clifford; Jennifer Cutone; Alexander M. Walker

Book ID: 116382033
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 185 KB
Volume: 78
Category: Article
ISSN: 0010-7824
DOI: 10.1016/j.contraception.2008.06.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of Thromboembolism in Women Taking

Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives: Seeger JD, Loughlin J, Eng PM, et al. Obstet Gynecol 2007;110:587–93

✍ Matthew Mendenhall 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Efficacy and Safety of the Combined Oral

Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/ Drospirenone (Yasmin®) in Healthy Chinese Women

✍ Dr Fan Guang-Sheng, Bian Mei-Lu, Cheng Li-Nan, Cao Xiao-Ming, Huang Zi-Rong, Han 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 156 KB

Effects of oral contraception with ethin

Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18–35 years old

✍ Donat De Groote; Sophie Perrier d'Hauterive; Axelle Pintiaux; Bénédicte Balteau; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Prospective study on the cytological asp

Prospective study on the cytological aspects of the nasal respiratory epithelium in premenopausal women taking 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive

✍ Salvatore Caruso; Agostino Serra; Calogero Grillo; Carmela Agnello; Lucia Di Mar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 490 KB

Prospective study on sexual behavior of

Prospective study on sexual behavior of women using 30 μg ethinylestradiol and 3 mg drospirenone oral contraceptive

✍ Salvatore Caruso; Carmela Agnello; Giorgia Intelisano; Marco Farina; Lucia Di Ma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 101 KB

The use of an oral contraceptive contain

The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days

✍ Jean-Michel Foidart; Patricia J. Sulak; Ilka Schellschmidt; Doris Zimmermann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 246 KB